CBS Outdoor Americas Climbs on First Day of Trading; FDA Advisory Panel Recommends Approval of Exact Sciences Corporation’s Cologuard

Follow this company

Companies Mentioned

03/31/2014 [ACCESSWIRE]

CBS Outdoor Americas Inc. (NYSE: CBSO) - For an in-depth report on CBS Outdoor Americas Inc. follow:

CBSO shares closed up 5.36% on almost 15.8 million shares traded. The stock was one of the biggest gainers on the NYSE on its first day of trading. The outdoor advertising subsidiary of broadcast company CBS Corp. raised $560 million in its initial public offering, pricing 20 million shares at $28 each, the high end of the expected range. The banks managing the IPO may buy another 3 million shares, adding to proceeds.

Exact Sciences Corporation (NASDAQ: EXAS) - For an in-depth report on Exact Sciences Corporation follow:

Shares of EXAS dropped 6.47% this past Friday with more than 9.3 million shares traded. The stock was one of the biggest decliners on the NASDAQ. The drop came despite an advisory panel for the U.S. Food and Drug Administration recommending approval of Cologuard. Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of colorectal cancer.

Tauriga Sciences, Inc. (OTC: TAUG) - For an in-depth report on Tauriga Sciences, Inc. follow:

Shares of TAUG closed down 15.07% on nearly 19 million shares traded this past Friday. The stock was one of the biggest decliners in the OTC market. Last week the company announced that its wholly owned subsidiary Pilus Energy LLC has commenced a five-phase, $1,700,000 USD commercial pilot test with the Environmental Protection Agency, utilizing Chicago Bridge & Iron Co. Federal Services serving as the third-party-contractor through the EPA's Test and Evaluation facility. This five phase commercial pilot will include significant testing of the Pilus Energy Electrogenic Bioreactor synthetic biology platform for generating value from wastewater.

Cybrdi, Inc. (OTC: CYDI) - For an in-depth report on Cybrdi, Inc. follow: 

Shares of CYDI exploded this past Friday to close up roughly 566% making it one of the biggest winners in the OTC market. The big gain came despite the fact that the company had no big news released. Volume traded was around 2.5 million shares.


Disclosure: is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.


Leave a comment...

Your Name